Picture [iito] Männer Ballett 650x80px
Document › Details

bioMérieux S.A.. (7/20/17). "Press Release: Second-Quarter 2017 Business Review".

Organisation Organisation bioMérieux S.A. (Euronext: BIM)
  Group Mérieux (Group)
Products Product in vitro diagnostics (IVD)
  Product 2 molecular diagnostics
Person Person Mérieux, Alexandre (Mérieux 201712– CEO at bioMérieux before Deputy CEO before VP Industrial Microbiology)

> Good sales dynamic confirmed in second-quarter 2017, with sales up 11.3% over the first half at constant exchange rates and scope of consolidation:
–– €1,134 million in sales
–– Up 13.3% as reported

> Noticeable performance from the Americas region, led by the success of FilmArray® and by the fast-paced growth of microbiology lines

> Robust growth in the Asia Pacific and Europe – Middle East – Africa regions, buoyed by all of the Group's strategic lines

Alexandre Mérieux, Chief Executive Officer, said: "bioMérieux's strong sales dynamic in first-half 2017 drove organic sales growth of over 11%. In light of this better-than-anticipated performance, we expect to achieve the higher end of our target organic sales growth range for the full year. More detailed information on our financial objectives for 2017 will be given on August 30, when we publish our first-half results."

Download [ ]

Record changed: 2017-08-04


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

More documents for Mérieux (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top